GAL and hepatocellular carcinoma: To investigate the targeting specificity of Gal-CMCS-Fe3O4-NPs for HCC cells, NPs were used to transfect plasmids into HepG2, L02, GES-1, U87, and SPCA-1 cell lines (Fig. 5B).